Tactile Systems Technology Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Tactile Systems Technology Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TCMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001027838
Board of directors
-
Boyd Vindell Washington · DirectorSince 2023
-
Carmen B. Volkart · DirectorSince 2023
-
Daniel L. Reuvers · Director · President and CEOSince 2023
-
David Brent Shafer · DirectorSince 2023
-
Raymond Huggenberger · DirectorSince 2023
-
Sheri Louise Dodd · Director · Chief Executive OfficerSince 2023
-
Valerie L. Asbury · DirectorSince 2023
-
William W. Burke · DirectorSince 2023
Chief executives
Daniel L. Reuvers
· President and CEO
Dates unknown
Sheri Louise Dodd
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 5 other boards.
- via David Brent Shafer
- via William W. Burke
- via William W. Burke
- via Carmen B. Volkart
- via David Brent Shafer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2024 | Ferstler Sherri Lee Officer (Senior VP, Sales) | Open-market sale | −1,550 | $13.07 | $20,259 |
| Aug 7, 2024 | Sheri Louise Dodd Director, Officer (Chief Executive Officer) | Grant or award | +64,959 | — | — |
| May 16, 2024 | Birkemeyer Elaine M. Officer (Chief Financial Officer) | Open-market sale | −3,041 | $13.68 | $41,601 |
| May 8, 2024 | William W. Burke Director | Open-market sale | −2,500 | $14.06 | $35,150 |
| May 8, 2024 | Valerie L. Asbury Director | Grant or award | +10,469 | — | — |
| May 8, 2024 | Sheri Louise Dodd Director | Grant or award | +10,469 | — | — |
| May 8, 2024 | Raymond Huggenberger Director | Grant or award | +10,469 | — | — |
| May 8, 2024 | David Brent Shafer Director | Grant or award | +10,469 | — | — |
| May 8, 2024 | Carmen B. Volkart Director | Grant or award | +10,469 | — | — |
| May 8, 2024 | Boyd Vindell Washington Director | Grant or award | +10,469 | — | — |
| May 8, 2024 | William W. Burke Director | Grant or award | +10,469 | — | — |
| May 6, 2024 | Burns Kristie Officer (Sr. VP Mktg & Clinical Affairs) | Open-market sale | −815 | $14.37 | $11,712 |
| Feb 29, 2024 | Burns Kristie Officer (Sr. VP Mktg & Clinical Affairs) | Open-market sale | −243 | $15.25 | $3,706 |
| Feb 29, 2024 | Daniel L. Reuvers Director, Officer (President and CEO) | Open-market sale | −1,396 | $15.25 | $21,289 |
| Feb 27, 2024 | Burns Kristie Officer (Sr. VP Mktg & Clinical Affairs) | Open-market sale | −1,091 | $15.58 | $16,998 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.